Opthea Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply
About OPT
Opthea Limited (OPT) is an ASX listed biopharmaceutical company which researches and develops novel therapeutic products based on targeting Vascular Endothelial Growth Factors (VEGF) C, D and R3. Since FY2014, the Company has been committed to the development of new therapies for the treatment of serious eye diseases that affect the back of the eye, or retina, and lead to vision loss. The Company's lead candidate was sozinibercept a VEGF C/D trap inhibitor being developed for use in conjunction with VEGF A inhibitors for the treatment of wet AMD and other retinal diseases.
Find out what a historical investment in Opthea Limited would be worth today using our OPT stock calculator.
Sector
Health Care
CEO
-
Industry
Biotechnology
Website
opthea.com
$821M
-2.96
-
$0.62
$0.60
$0.60
$1.17
$0.59
Ready to start your investing journey with Stake?
Open an accountAnnouncements
OPT FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in OPT
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in OPT
on Stake
Buy OPT from A$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
